PortalPublikationenSingle-incision transaxillary robotic total thyroidectomy fo...

Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation

Standard

Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation. / Lörincz, Balazs B; Möckelmann, Nikolaus; Knecht, Rainald.

in: EUR ARCH OTO-RHINO-L, Jahrgang 271, Nr. 12, 01.12.2014, S. 3349-53.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Lörincz, BB, Möckelmann, N & Knecht, R 2014, 'Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation', EUR ARCH OTO-RHINO-L, Jg. 271, Nr. 12, S. 3349-53. https://doi.org/10.1007/s00405-014-3250-9

APA

Lörincz, B. B., Möckelmann, N., & Knecht, R. (2014). Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation. EUR ARCH OTO-RHINO-L, 271(12), 3349-53. https://doi.org/10.1007/s00405-014-3250-9

Vancouver

Lörincz BB, Möckelmann N, Knecht R. Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation. EUR ARCH OTO-RHINO-L. 2014 Dez 1;271(12):3349-53. https://doi.org/10.1007/s00405-014-3250-9

Bibtex

@article{761b6e70839f4c30ba8f54d2fa693401,
title = "Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation",
abstract = "BACKGROUND: Graves' disease represents a relative contraindication for robotic thyroidectomy due to increased vascularity with a higher risk of intraoperative bleeding. With a novel robotic instrumentation, however, it is possible to reduce this risk considerably.METHODS: A 30-year-old female patient with Graves' disease and keloid-prone olive skin underwent a single-incision transaxillary robotic total thyroidectomy through the left axilla using an 8-mm Fenestrated bipolar forceps instead of the standard 8-mm ProGrasp forceps.RESULTS: Total blood loss was 25 ml, and robotic console time was 132 min. There was no postoperative recurrent palsy. Postoperative parathormone level was 47 ng/l (preop.: 56 ng/l), and serum calcium level was normal at 2,17 mmol/l (preop.: 2,23 mmol/l).CONCLUSION: Transaxillary robotic surgery (TARS) with unilateral single-incision access is feasible and safe for Graves' disease with minimal blood loss and reduced risk of conversion thanks to the bipolar capability of the 8-mm Fenestrated bipolar forceps.",
author = "L{\"o}rincz, {Balazs B} and Nikolaus M{\"o}ckelmann and Rainald Knecht",
year = "2014",
month = dec,
day = "1",
doi = "10.1007/s00405-014-3250-9",
language = "English",
volume = "271",
pages = "3349--53",
journal = "EUR ARCH OTO-RHINO-L",
issn = "0937-4477",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation

AU - Lörincz, Balazs B

AU - Möckelmann, Nikolaus

AU - Knecht, Rainald

PY - 2014/12/1

Y1 - 2014/12/1

N2 - BACKGROUND: Graves' disease represents a relative contraindication for robotic thyroidectomy due to increased vascularity with a higher risk of intraoperative bleeding. With a novel robotic instrumentation, however, it is possible to reduce this risk considerably.METHODS: A 30-year-old female patient with Graves' disease and keloid-prone olive skin underwent a single-incision transaxillary robotic total thyroidectomy through the left axilla using an 8-mm Fenestrated bipolar forceps instead of the standard 8-mm ProGrasp forceps.RESULTS: Total blood loss was 25 ml, and robotic console time was 132 min. There was no postoperative recurrent palsy. Postoperative parathormone level was 47 ng/l (preop.: 56 ng/l), and serum calcium level was normal at 2,17 mmol/l (preop.: 2,23 mmol/l).CONCLUSION: Transaxillary robotic surgery (TARS) with unilateral single-incision access is feasible and safe for Graves' disease with minimal blood loss and reduced risk of conversion thanks to the bipolar capability of the 8-mm Fenestrated bipolar forceps.

AB - BACKGROUND: Graves' disease represents a relative contraindication for robotic thyroidectomy due to increased vascularity with a higher risk of intraoperative bleeding. With a novel robotic instrumentation, however, it is possible to reduce this risk considerably.METHODS: A 30-year-old female patient with Graves' disease and keloid-prone olive skin underwent a single-incision transaxillary robotic total thyroidectomy through the left axilla using an 8-mm Fenestrated bipolar forceps instead of the standard 8-mm ProGrasp forceps.RESULTS: Total blood loss was 25 ml, and robotic console time was 132 min. There was no postoperative recurrent palsy. Postoperative parathormone level was 47 ng/l (preop.: 56 ng/l), and serum calcium level was normal at 2,17 mmol/l (preop.: 2,23 mmol/l).CONCLUSION: Transaxillary robotic surgery (TARS) with unilateral single-incision access is feasible and safe for Graves' disease with minimal blood loss and reduced risk of conversion thanks to the bipolar capability of the 8-mm Fenestrated bipolar forceps.

U2 - 10.1007/s00405-014-3250-9

DO - 10.1007/s00405-014-3250-9

M3 - SCORING: Journal article

C2 - 25142080

VL - 271

SP - 3349

EP - 3353

JO - EUR ARCH OTO-RHINO-L

JF - EUR ARCH OTO-RHINO-L

SN - 0937-4477

IS - 12

ER -